Answers are grounded in this paper and cite their sources.
This comparative study evaluated biomass growth kinetics, hydrocarbon accumulation dynamics, and compositional signatures across three representative Botryococcus braunii chemical races, namely UTEX 572 (Race A), Ayamè (Race B), and Madras 3 (Race L), over a 42-day batch cultivation period. Growth trajectories revealed differing strain-specific kinetics. Specifically, Specifically, UTEX 572 completed its exponential phase rapidly from days 3 to 12, whereas Ayamè and Madras 3 required an extended initial acclimation period before initiating active growth phase from day 12 to day 30. During exponential growth, UTEX 572 achieved a maximum specific growth rate of 0.168 ± 0.008 day−1 and a peak volumetric productivity of 0.029 ± 0.001 g L−1 day−1, significantly exceeding Ayamè and Madras 3. Conversely, Ayamè attained a peak hydrocarbon content of 27.2 ± 1.4% and a final yield of 0.466 g L−1 upon entering the stationary phase. Gas chromatography-mass spectrometry confirmed that signature homologous series distributions remained stable across all growth phases, despite subtle temporal isomeric shifts. Crucially, these performance patter represent strain-specific acclimation constrained strictly by the standardized baseline framework, Bold-3N medium at 24 °C, rather than defining absolute limits on intrinsic biological potential. These findings demonstrate a physiological trade-off between rapid population turnover and storage accumulation under unified baseline conditions. Consequently, UTEX 572 serves as an efficient candidate for short-cycle harvesting systems, whereas higher-accumulating strains like Ayamè represent valuable targets for extended extraction strategies pending further environmental optimization.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: